Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q1 2025 · 10-Q
Revenue$23.43M$23.43M+26.4% vs Q1 2024 Net Income-$3.53M-$3.53MN/M vs Q1 2024 EPS Diluted-$0.41-$0.41N/M vs Q1 2024 Gross Profit$21,599,129+29.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Operating Cash Flow-$1,998,884N/M Free Cash Flowderived-$3,721,533N/M Margins · derivedGross margin92.2%+2.4 pt vs Q1 2024
Operating margin3.5%+11.8 pt vs Q1 2024
Net margin-15.1%−5.5 pt vs Q1 2024
ended Mar 31, 2025 · filed May 14, 2025 · 44 d after period end